3 Year Absolute Returns
42.15% ↑
NAV (₹) on 20 Aug 2026
29.63
1 Day NAV Change
0.14%
Risk Level
Very High Risk
Rating
-
DSP Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by DSP Investment Managers Pvt. Ltd.. Launched on 12 Nov 2018, investors can start with a lumpsum investment ... Read more
AUM
₹ 3,639.29 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 66.38% |
| Hospitals & Medical Services | 16.70% |
| Foreign Securities | 8.35% |
| Treps/Reverse Repo | 5.93% |
| Finance - Non Life Insurance | 1.08% |
| International Mutual Fund Units | 0.87% |
| Net Receivables/(Payables) | 0.53% |
| Medical Equipment & Accessories | 0.16% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 8.42% | ₹ 305.66 | Pharmaceuticals |
| IPCA Laboratories Ltd | 8.17% | ₹ 296.49 | Pharmaceuticals |
| Cipla Ltd | 8.13% | ₹ 294.84 | Pharmaceuticals |
| Sai Life Sciences Ltd | 7.10% | ₹ 257.41 | Pharmaceuticals |
| Gland Pharma Ltd | 6.35% | ₹ 230.44 | Pharmaceuticals |
| TREPS / Reverse Repo Investments | 5.93% | ₹ 215.28 | Others |
| Apollo Hospitals Enterprise Ltd | 5.81% | ₹ 210.88 | Hospitals & Medical Services |
| Globus Medical Inc | 5.57% | ₹ 201.98 | Others |
| Alkem Laboratories Ltd | 4.66% | ₹ 169.01 | Pharmaceuticals |
| Cohance Lifesciences Ltd | 3.75% | ₹ 136.14 | Pharmaceuticals |
| Vijaya Diagnostic Centre Ltd | 3.47% | ₹ 125.77 | Hospitals & Medical Services |
| Alembic Pharmaceuticals Ltd | 3.17% | ₹ 114.98 | Pharmaceuticals |
| Manipal Health Enterprises Ltd | 3.02% | ₹ 109.71 | Hospitals & Medical Services |
| Procter & Gamble Health Ltd | 2.90% | ₹ 105.20 | Pharmaceuticals |
| Kovai Medical Center And Hospital Ltd | 2.74% | ₹ 99.29 | Hospitals & Medical Services |
| Pfizer Ltd | 2.73% | ₹ 99.22 | Pharmaceuticals |
| Divi's Laboratories Ltd | 2.34% | ₹ 84.79 | Pharmaceuticals |
| Indoco Remedies Ltd | 1.96% | ₹ 71.24 | Pharmaceuticals |
| Concord Biotech Ltd | 1.95% | ₹ 70.57 | Pharmaceuticals |
| Intuitive Surgical Inc | 1.74% | ₹ 63.24 | Others |
| Unichem Laboratories Ltd | 1.59% | ₹ 57.73 | Pharmaceuticals |
| Syngene International Ltd | 1.33% | ₹ 48.22 | Pharmaceuticals |
| Nephrocare Health Services Ltd | 1.19% | ₹ 43.28 | Hospitals & Medical Services |
| ICICI Lombard General Insurance Co Ltd | 1.08% | ₹ 39.20 | Finance - Non Life Insurance |
| Aarti Drugs Ltd | 0.99% | ₹ 36.02 | Pharmaceuticals |
| Abbott Laboratories | 0.88% | ₹ 31.85 | Others |
| Global X Funds - Global X Genomics & Biotechnology ETF | 0.87% | ₹ 31.64 | Others |
| Eris Lifesciences Ltd | 0.84% | ₹ 30.60 | Pharmaceuticals |
| Net Receivables/Payables | 0.53% | ₹ 29.79 | Others |
| Jupiter Life Line Hospitals Ltd | 0.47% | ₹ 17.12 | Hospitals & Medical Services |
| Grail Inc | 0.16% | ₹ 5.71 | Others |
| Laxmi Dental Ltd | 0.16% | ₹ 5.96 | Medical Equipment & Accessories |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 8.19% | 7.15% | 1.90% | 12.44% |
| Category returns | 4.95% | 7.39% | 6.92% | 23.87% |
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹36.39 | 148.38% | 303.80% | 0.00% | ₹947 | 1.24% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹36.39 | 148.38% | 303.80% | 0.00% | ₹947 | 1.24% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹36.39 | 148.38% | 303.80% | 0.00% | ₹947 | 1.24% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹34 | 145.04% | 287.42% | 0.00% | ₹947 | 2.53% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹34 | 145.04% | 287.42% | 0.00% | ₹947 | 2.53% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹34 | 145.04% | 287.42% | 0.00% | ₹947 | 2.53% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹31.60 | 32.71% | 184.15% | 0.00% | ₹10,709 | 0.90% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹31.60 | 32.71% | 184.15% | 0.00% | ₹10,709 | 0.90% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹31.60 | 32.71% | 184.15% | 0.00% | ₹10,709 | 0.90% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹30.49 | 31.40% | 174.92% | 0.00% | ₹10,709 | 1.79% |
Very High
|
What is the current NAV of DSP Healthcare Fund - Direct Plan IDCW-Reinvestment?
What is the fund size (AUM) of DSP Healthcare Fund - Direct Plan IDCW-Reinvestment?
What are the historical returns of DSP Healthcare Fund - Direct Plan IDCW-Reinvestment?
What is the risk level of DSP Healthcare Fund - Direct Plan IDCW-Reinvestment?
What is the minimum investment amount for DSP Healthcare Fund - Direct Plan IDCW-Reinvestment?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article